The study aimed to investigate the impact of a delay of 12h between sample collection and HbA1c measurement. We propose an easy method to determine the adequacy of removal of HbA1d and in case of insufficient removal suggest measurement of HbA1c 12h after collection (Diabetes Research and Clinical Practice)
Diabetes News
Category: Monitoring
Future of inpatient diabetes management: glucose the sixth vital sign
The future is in the use of insulin pumps controlled by continuous glucose monitors. This technology is complex and has not yet become standard. The development of future inpatient diabetes care will depend on adaptation of hospital systems to advance the new technology (Expert Review of Endocrinology & Metabolism)
Low Blood Glucose Index Is Predictive of Hypoglycemia in Pump Therapy
Baseline LBGI predicts the outcome of type 1 diabetic patients who switch to CSII in terms of hypoglycemia (Diabetes Care)
Trabecular Bone Score and Diabetes-Related Fracture Risk
Lumbar spine TBS predicts osteoporotic fractures in those with diabetes, and captures a larger portion of the diabetes-associated fracture risk than BMD(Journal of Clinical Endocrinology & Metabolism)
Circulating cytokine levels, DM and IR in a population-based sample
We found that subjects with diabetes, metabolic syndrome and increased insulin resistance had increased levels of IL6, TNF-a and hs-CRP, while no association was found with IL-1ß. (Clinical Endocrinology)
Plasma YKL-40 Predicts 10-Year CV and All-cause Mortality T2D
Plasma YKL-40 concentration is an independent predictor of 10-year all-cause and cardiovascular mortality in subjects with type 2 diabetes. Further investigations on the role of YKL-40 in the pathogenesis of CVD are required to elucidate the underlying mechanisms (Clinical Endocrinology)
Comparison of annual variability in HbA1c and glycated T1D v T2D
The annual variability in GA was greater than that in HbA1c. In addition, the annual variability in HbA1c and that in GA in the T1DM patients were greater than in the T2DM patients. Our findings suggest that GA more accurately reflects long-term variations in PG levels than HbA1c (Diabetes and Its Complications)
All-cause mortality & glycated haemoglobin newly diagnosed T2D
A target of HbA1C between 6.0 and 6.5% is appropriate for individuals newly diagnosed with type 2 diabetes without cardiovascular disease. However, a target of
Continuous glucose monitoring: current clinical use
Four kinds of subcutaneous continuous glucose monitoring (CGM) machines have been currently introduced in clinical practice. These machines exhibit real-time glucose on the monitor every 5 minutes and have alarms to indicate hypoglycaemia and hyperglycaemia. However, thus far, there is no clear consensus about the clinical indications for CGM in actual clinical practice (Diabetes/Metabolism Research and Reviews)
Linguistic & Psychometric Validation of Diabetes Quality-of-Life Scale UK
The DSQOLS captures the impact of detailed aspects of modern type 1 diabetes management (e.g., carbohydrate counting and flexible insulin dose adjustment) that are now routine in many parts of the U.K. and Ireland. The U.K. English version of the DSQOLS offers a valuable tool for assessing the impact of treatment approaches on QoL in adults with type 1 diabetes (Diabetes Care)
Changes in serum phosphate during treatment of diabetic ketoacidosis
The severity of subsequent hypophosphataemia can be predicted by the degree of metabolic acidosis on presentation. As profound hypophosphataemia can be associated with serious complications, clinicians should recognise the likelihood of this biochemical derangement in those DKA patients presenting with profound acidosis (Internal Medicine Journal)
A diabetes-predictive amino acid score and future cardiovascular disease
This study identifies branched-chain and aromatic amino acids as novel markers of CVD development and as an early link between diabetes and CVD susceptibility (European Heart Journal)
Partner support, social-cognitive variables and self-monitoring T2D
The results show the importance of partners’ support and social-cognitive variables, regarding self-monitoring of blood glucose, on patients’ adherence(European Diabetes Nursing)
Macroalbuminuria Predicts Severe Hypoglycemia in T2D
The development of SH was independently associated with duration of diabetes and presence of macroalbuminuria, even with normal renal function in patients with type 2 diabetes (Diabetes Care)
Assessment Social Context & Glucose Monitoring Adherence Adolescents
Desire to blend in may support glucose monitoring adherence and desire to impress others may impede this behavior in adolescents with T1D. Other dimensions of social context were not linked to checking glucose in this study (Journal of Adolescent Heath)
Development and psychometric properties of a new social support scale
The findings showed that the designed questionnaire was a valid and reliable instrument for measuring social support for self-care in middle-aged patients with type II diabetes. It is an easy to use questionnaire and contains the most significant diabetes related behaviors that need continuous support for self-care (BMC Public Health)
Association Urinary Markers of Nucleic Acid Oxidation and Mortality T2D
The RNA oxidation marker 8-oxoGuo is an independent predictor of mortality in patients with established and treated type 2 diabetes, and changes in 8-oxoGuo during the first 6 years after diagnosis are associated with mortality (Diabetes Care)
GI, glycemic load not associated with risk of T2D in EU
Our study shows that digestible carbohydrate intake is not associated with diabetes risk and suggests that diabetes risk with high-GI and -GL diets may be more modest than initial studies suggested. (Journal of the Nutrition)
Intrapersonal HbA1c variability – risk of progression of nephropathy T2D
In patients with Type 2 diabetes, the risk of progression of nephropathy increases significantly with HbA1c variability, independently of the influence of updated mean HbA1c (Diabetic Medicine)
Evaluation of bone loss in Diabetic Postmenopausal Women
Osteopenia and osteoporosis is more common in diabetic postmenopausal women compare to the non-diabetic postmenopausal women (Journal of Research in Medical Sciences)